Related Experiment Video

Updated: Mar 16, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

Immunizations in Children Requiring Warfarin Therapy

Mary E Bauman1, Michael Hawkes, Aisha Bruce

  • 1Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.

Journal of Pediatric Hematology/Oncology
|August 23, 2016
PubMed

Insights

Children on warfarin therapy can safely receive immunizations. This study found no increased risk of bleeding or bruising, demonstrating the safety of childhood vaccinations for these patients.

Area of Science:

  • Pediatric Medicine
  • Pharmacology
  • Immunology

Background:

  • Children requiring chronic warfarin therapy are a growing population.
  • Immunizations are crucial for this group due to potential immune deficiencies.
  • Concerns exist regarding vaccine administration during anticoagulation, specifically hematoma risk and warfarin metabolism effects.

Purpose of the Study:

  • To evaluate the safety of administering vaccines to children on therapeutic warfarin therapy.
  • To assess the impact of immunizations on warfarin's effect, measured by the International Normalized Ratio (INR).
  • To determine the incidence of clinically relevant hematomas or bruising following immunization in this cohort.

Main Methods:

  • Children receiving therapeutic warfarin therapy were assessed post-immunization.
  • Warfarin effect was monitored using the International Normalized Ratio (INR).
  • Incidence of hematomas and bruising was recorded and analyzed.

Main Results:

  • No clinically relevant negative outcomes were observed after immunizations.
  • The administration of vaccines did not lead to significant adverse events.
  • INR levels remained within therapeutic ranges without concerning fluctuations.

Conclusions:

  • Immunizations can be safely administered to pediatric patients on therapeutic warfarin therapy.
  • Vaccination does not appear to negatively impact warfarin anticoagulation or cause significant bleeding complications.
  • This study supports routine immunization schedules for children requiring warfarin treatment.

More Related Videos

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.3K
Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

575

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
453
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
682
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312